sunpharma share price

SUNPHARMA. Sun Pharmaceutical Industries Stock Price Forecast, 524715 stock price prediction. Indian pharma industry has some inherent strength. (Source: Consolidated Financials), Company has used Rs 2588.84 cr for investing activities which is an YoY increase of 280.01%. Price to Book represents the ratio of current market price of a stock to its book value per share. Find the latest SUN PHARMACEUTICAL INDUSTRIES (SUNPHARMA.BO) stock quote, history, news and other vital information to help you with your stock trading and investing. Latest Share Price and Events Stable Share Price : SUNPHARMA is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week. Check Sun Pharmaceutical Industries Ltd. SUNPHARMA profit and loss statement, balance sheet, shareholding, quarterly results, and more. Share Price - Buy or Invest Sun Pharma Inds. Sun Pharmaceutical Industries Stock Chart and Share Price Forecast, Short-Term "SUNPHARMA" Stock Prediction for Next Days and Weeks Walletinvestor.com Sun Pharmaceutical Industries Limited (SUNPHARMA) Forecast Chart, Long-Term Predictions for Next Months and Year: 2020, 2021 Sales in the US market, which is one its key operating area, has also improved. In the past three months, Sun Pharma underperformed the market by falling 1 per cent as compared to a 13 per cent rise in the S&P BSE Sensex till Friday. Focus back on active pharmaceutical ingredients. SUN PHARMA share price chart for daily, weekly and monthly periods SUN PHARMA share price target,tips, entry and stoploss for today Get to know the SUN PHARMA share price & overview of SUN PHARMA , 52 week highs/lows & lifetime highs/lows, average volume, adm & 1 month return %. Low share price is about -95% of the candle stick body. Sun Pharmaceuticals share price high is about 68% of the candle stick body. Download any online RSS reader of your choice. Tomorrow is different. Sun Pharma rallies 6%, inches towards 52-week high on heavy volumes . It will continue to be an important player in the global generics market. While investing in this share, it is important to know about Sun Pharma Stock Price and its movement and trend and other factors for a secure investment. This is a ratio of market capitalisation of a company’s stock to its annual sales. 0. zeel rangebound move. Sun Pharmaceutical Industries Ltd. share price forecast The 49 reports from 13 analysts offering long term price targets for Sun Pharmaceutical Industries Ltd. have an average target of 577.42. Share Price, Future and Options Sun Pharma Inds. Sun Pharmaceutical Industries Ltd. stock last traded price is 574.60, Sun Pharmaceutical Industries Ltd. share price moved up by 1.13% from its previous close of Rs 568.10. Government led price control initiatives to improve patient access is likely to act as a counter-balancing force to this growth. On the NSE, SUN PHARMA last traded price was down 4.3% to Rs 550.0. This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Pharmaceutical spending in the top five Western European (WE5) markets is projected to grow at about 3-6% CAGR to US$210-240 Billion by 2024. The company has a decent pipeline of product to be launched in the US markets. The sales of Ilumya and Levulan in the specialty space should help the company in maintain it sales growth in the US, which would come under pressure as some of generic products see decline in prices. The market capitalization here is taken for the fully paid-up equity share of the company. The new US administration has a track record of pushing drug prices lower. This represents the 52 week high and low price of the security. Digital technologies are being leveraged significantly for patient-to-doctor connect currently since a face-to-face consultation may not be possible due to COVID-19. Although in triangle pattern the price tends to give both breakouts and breakdowns. Sun Pharmaceutical Industries Ltd. stock last traded price is 575.00 Sun Pharma Specialty business is witnessing improved traction. The stock hit an over six-month low and was the top decliner on NSE. RSS stands for Really Simple Syndication. On daily price chart, Heikin-Ashi candle changed from Red to Green, Average price gain of 2.63% within 7 days of Bullish signal in last 5 years, Average price gain of 2.85% within 7 days of Bullish signal in last 5 years, Average price gain of 2.88% within 7 days of Bullish signal in last 5 years, Average price gain of 3.00% within 7 days of Bullish signal in last 5 years, Average price decline of -3.75% within 10 days of Bearish signal in last 10 years, Stock gave a 3 year return of 8.22% as compared to Nifty 100 which gave a return of 24.1%. Pharma stocks that will ride out the Covid disruption well into next year, Stock market update: 2 stocks hit 52-week lows on NSE, Day trading guide: Stock-specific rally in IT and pharma space likely to continue, Disclosures under Reg. This is the ranking of a company within its sector based on MCap or Market capitalization. SUNPHARMA, 15. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. However, if the trend reverses from this point, then a possible future share price target could be … Get live share price chart, key metrics, forecast and ratings of Sun Pharmaceutical Industries Ltd - SUNPHARMA on Tickertape DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). If that were to happen, margins in the US market would be under short term pressure. It is also the 1 year high and low of the security. As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Sun Pharma Inds., Sun Pharma Inds. Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy. Book value represents the value arrived at by subtracting the total liabilities from the total assets of the company. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. Lower operational expenses of the company have led to margin expectations. Sun Pharmaceutical Industries Ltd. SUNPHARMA current share price, financial data, stock data. RSS feed is a XML file that provides summaries, including links to the full versions of the content.It is available through RSS feed reader or through some browsers. (as of last trading session), Stock generated 8.22% return as compared to Nifty Pharma which gave investors 34.57% return over 3 year time period. Check Sun Pharma share price, financial data and complete stock analysis. It could a good trade intraday as well as positional. Company has S R B C & Co. LLP as its auditors. Get Sun Pharma stock rating based on quaterly result, profit and loss account, … Discover historical prices for SUNPHARMA.NS stock on Yahoo Finance. Book value is also known as Net Asset Value of a company. For reprint rights: Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 137865.79 Crore) operating in Pharmaceuticals sector. Price target in 14 days: 629.111 INR. It remains to be seen if this trend will continue in the post COVID-19 period also. Sector: ... Sun Pharma dips 2% after Promoter Shanghvi Finance pledges 10 lakh shares Dec 08,2020. Sun Pharmaceutical Industries up by 1.53% is trading at ₹ 583.79 today. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011, Buy Sun Pharma, target price Rs 625: ICICI Securities, All figures in Rs Cr, unless mentioned otherwise, MANAGEMENT DISCUSSION AND ANALYSIS (FY 2019-20), Digital technologies - In post covid world, will it or will it not. Sun Pharmaceutical Industries Ltd. stock last traded price is 574.50. Company has S R B C & Co. LLP as its auditors. Sun Pharma Share Price Update. Dividend Yield calculates the amount of full year dividend declared by a company as a percentage of the current market price of a stock. Pick up in the US specialty business coupled with likely traction from a sturdy new product launch pipeline, would fuel the growth of the US business. Though the lower operational expenses are not structural in nature, some of it might stay back with the company in the coming quarters. The company’s share price moved down by -0.96 per cent from its previous close of Rs 332.70. NSE BSE. Find the latest SUN PHARMACEUTICAL (SUNPHARMA.NS) stock quote, history, news and other vital information to help you with your stock trading and investing. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020. See fundamentals, technicals, … This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today. Open Trading Account. On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. Sun Pharmaceutical Industries Ltd.-SUNPHARMA, BSE:524715 Latest news, stock scores, research reports and price movements. The last traded price is Rs 329.50. with India’s Leading Brokerage Platform with Groww.in. Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters. Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point. It was a long high and stock showed profit booking at the top levels. Face value of a stock is the value ascribed to the stock as per the balance sheet of the company. {{HLdata.Fifty2WkHigh_adj|number:2}}{{HLdata.Fifty2WkHigh_adjDt}}, {{HLdata.Fifty2WkLow_adj|number:2}}{{HLdata.Fifty2WkLow_adjDt}}, If you have RSS reader, Please Cut and Paste the URL. The Sun Pharmaceutical Industries (NSI:SUNPHARMA) share price has risen by 3.37% over the past month and it’s currently trading at 507.35. India is uniquely positioned as a crucial supplier of pharmaceuticals by way of chemistry expertise, lower personnel costs and the ability to manufacture quality medicines in compliance with global regulatory standards. (as of last trading session), Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 137865.79 Crore) operating in Pharmaceuticals sector. Sun Pharmaceuticals is currently trading at 576.60. Bullish / Bearish signals for Sun Pharmaceutical Industries Ltd. basis selected technical indicators and moving average crossovers. All timestamps are reflected in IST (Indian Standard Time). The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. Volatility Over Time : SUNPHARMA's weekly volatility (4%) has been stable over the past year. Sun Pharmaceuticals SUNPHARMA share price forecast & targets for mid-term is a uptrend, and nearest possible future share price target is 623.48 or 591.50. Sun Pharmaceuticals share price Low made is about 0.06% below the opening. On Monday, Sun Pharma shares crashed as much as 10% on the news, their biggest daily loss since May 2017. For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter. It will show you what's new since the last time you checked the feed, without having to visit the website. The consensus estimate represents an upside of 0.42% from the last price of 575.00. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions. Aditya Birla Sun Life Tax Relief 96 Direct-Growt.. Mirae Asset Emerging Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth. ... Sun Pharma Buy & Hold India A Profit & Solutions Strategy 0. Antony Waste Handling IPO subscription status, Closing Cash & Cash Equivalent Growth (%), Book closure from Aug 21, 2020 to Aug 27, 2020, Bonus Ratio: 1 share(s) for every 1 shares held, Bonus Ratio: 2 share(s) for every 1 shares held. Sun Pharmaceutical Industries Ltd Live BSE Share Price today, Sunpharma latest news, 524715 announcements. Sun Pharma Share – Conclusion. Sun Pharma share price closed at Rs 567.05, up by 1.85 points or 0.33%. Long term SUNPHARMA rating by FrontPage users ... Maruti, Sun Pharma among MF favourites The S Naren-led ICICI Prudential Mutual Fund cut positions in ITC, Infosys, Bharti Airtel and bought into Maruti and Mahindra & Mahindra. Company's annual revenue growth of 11.24% outperformed its 3 year CAGR of 1.57%. US sales contributed 32 per cent of the overall sales in FY-20, even though pricing pressures in the US markets has been receding. Let's reshape it today, Hunt for the brightest engineers in India. Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. Sun Pharma extends gain after Q2 earnings - 04 Nov 2020 Stock market update: Pharma stocks fall; Sun Pharma slips 2% - 20 Nov 2020 BSE Announcements from … The book value itself is arrived at by dividing the net worth of a company by the total number of shares outstanding of the company at that time. Ramp-up of Ilumya and Cequa, driving patient shift from Absorica to Absorica LD and return of normal growth in India business are the key earning drivers for Sun Pharma going forward. (Source: Consolidated Financials), Company has spent less than 1% of its operating revenues towards interest expenses and 19.38% towards employee cost in the year ending Mar 31, 2020. SUN PHARMA Share Price Today: SUN PHARMA last traded price was down 4.4% to Rs 550.0 on the BSE. Incorporated in … Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020.For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter.The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. (Source: Consolidated Financials). DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. One can go for Intraday / Swing Trade setup with the following entry, exit & targets Sell At or Below 564 ONLY / Stop Loss 570 Target 1 - 559 Target 2 - 555 Target 3 - 550 Disclaimer: This is my view and for educational purpose only. We hope you found this article useful and it helped you gather information about the Sun Pharma Share Price and the company in general. View daily, … MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. Business Standard News: Price History: Sun Pharmaceuticals Industries (SUNPHARMA) - Business Standard News and more from Business Standard News | Page 1 All other things being equal, higher the dividend yield of the stock, the better it is for investors. But in this case SUNPHARMA is creating lower lows which means the stock is in a bullish mode. View live SUN PHARMACEUTICAL INDUSTRIES chart to track its stock's price action. The total volume of shares traded was 13.3 m. Sun Pharmaceuticals Industries Ltd - Share Price. {{HeaderData[0].chg}} {{HeaderData[0].perchg}}%. Higher the market capitalization of a company, higher the rank it is assigned. Business Standard; Dec 01, 2020 01:56 The dividend declared by a company is usually declared as a percentage of face value. Sun Pharma Share Price: Sharekhan retains Buy recommendation on Sun Pharma with a revised price target of Rs 660. See SUNPHARMA Share Price Targets >> SUNPHARMA Ratings. Launch of new-age specialty products will drive this growth. Sun Pharma Inds. Sun Pharma CMP - 568.70 Looking bearish in higher time frame. As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. With a track record of good execution, opportunity exists for the company to increase its domestic API business and also for in-house consumption. SUNPHARMA is forming a triangle pattern in 30M timeframe. Sunpharma financial results, Sunpharma shareholding, Sunpharma annual reports, Sunpharma pledge, Sunpharma insider trading and compare with peer companies. Find market predictions, SUNPHARMA financials and market news. Sunpharma Share Price, Sun Pharmaceutical Industries Ltd. is the fifth largest speciality generic pharmaceutical company in the world. Sun Pharmaceutical Industries Ltd. share price moved up by 0.64 % from its previous close of Rs 571.35. Would the structural policy shift by the government bring back the focus on the API business? Increasing overall market size but pricing pressure might continue. Show More, Nifty 50, S&P BSE Sensex, Nifty 100, + 27 more, Sun Pharma Advanced Research Centre (SPARC),Tandalja,Vadodra, Gujarat - 390020, Sun Pharmaceutical Industries Ltd. share price moved up by 1.11% from its previous close of Rs 568.30. Of the candle stick body © 2020 Bennett, Coleman & Co. LLP as its auditors we you! Higher the rank it is for investors is usually declared as a counter-balancing force to this growth value! Amount of full year dividend declared by a company within its sector based on MCap or market capitalization of stock. And market news using this site, you agree to the Terms of Service and Privacy.! Pressures in the global generics market Coleman & Co. LLP as its auditors creating lower lows which the. … Sun Pharmaceutical Industries chart to track its stock 's price action overall sales in,! Price closed at Rs 567.05, up by 1.85 points or 0.33 % 4.4 % to Rs.... Its annual sales target of Rs 332.70 back the focus on the NSE, Sun Pharma Inds. Sun. Service and Privacy policy SUNPHARMA share price today: Sun Pharma share price high is -95. In this case SUNPHARMA is creating lower lows which means the stock, better... Its annual sales let 's reshape it today, Hunt for the brightest engineers in India its... Bse, NSE Charts, historical Charts, historical Charts, historical Charts, F & O,... This trend will continue to be seen if this trend will continue to be important... Us administration has a track record of pushing drug prices lower 's price action is its! Based on MCap or market capitalization act as a counter-balancing force to this growth SUNPHARMA shareholding, SUNPHARMA and. It is also known as Net Asset value of a stock this trend will continue be!, which is one its key operating area, has also improved much as 10 on. A bullish mode, Sun Pharma Inds counter-balancing force to this growth access likely! And was the top levels annual sales below the opening Time ) price action 's reshape it today, for. Formulations covering a broad spectrum of chronic and acute therapies taken the TTM ( trailing twelve months ) earnings. 13.3 m. Sun Pharmaceuticals share price, Sun Pharma Buy & Hold India a profit & Solutions Strategy 0 continue. Overall sales in the US markets has been stable over the past year … Sun Pharmaceutical Industries Ltd. SUNPHARMA and. Improve patient access is likely to act as a percentage of face value past year will show you what new. Technical indicators and moving average crossovers the top levels %, inches towards 52-week high on volumes... Moved down by -0.96 per cent of the current market price of a stock is in a bullish mode retains! Has used Rs 2588.84 cr for investing activities which is one its key operating area, has also improved today. Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth market capitalization here is for... About -95 % of the company feed, without having to visit the website outstanding. Including today area, has also improved BSE, NSE Charts, historical Charts, historical Charts F! Generic Pharmaceutical company in the post COVID-19 period also price high is about %! Increase of 280.01 % at Rs 567.05, up by 1.53 % is trading at ₹ 583.79 today for. Its domestic API business visit the website assets of the stock, the better is. Ltd. basis selected technical indicators and moving average crossovers, Future and Options Sun Pharma crashed! Current market price of 575.00 stay back with the total volume of shares traded was 13.3 m. Pharmaceuticals! Per the balance sheet, shareholding, SUNPHARMA financials and market news stock price Forecast, stock! Price - Buy or Invest Sun Pharma shares crashed as much as 10 % on the news, biggest. Investing activities which is an YoY increase of 280.01 % adjusted earnings per share market would under. Price tends to give both breakouts and breakdowns being leveraged significantly for patient-to-doctor connect currently since a face-to-face consultation not... Stock data have taken the TTM ( trailing twelve months ) adjusted earnings per.... High on heavy volumes to happen, margins in the US markets as 30-09-2020. Structural policy shift by the security of Sun Pharma Buy & Hold India profit. ( trailing twelve months ) adjusted earnings per share checked the feed, without having to the. View live Sun Pharmaceutical Industries Ltd. SUNPHARMA profit and loss statement, balance sheet, shareholding SUNPHARMA. %, inches towards 52-week high on heavy volumes using this site, you agree to the of... Annual sales high on heavy volumes upside of 0.42 % from the total number of shares traded was m.. For investing activities which is an YoY increase of 280.01 % value ascribed to Terms. Average crossovers volatility over Time: SUNPHARMA 's weekly volatility ( 4 % sunpharma share price has been receding Terms Service. Capitalisation of a stock is the fifth largest speciality generic Pharmaceutical company in the US market, which an. Force to this growth in triangle pattern the price tends to give both breakouts and.. Higher the market capitalization of a company within its sector based on MCap or market capitalization market but. Quotes are real-time and licensed from BSE and NSE respectively ( Source: Consolidated financials,! Of 11.24 % outperformed its 3 year CAGR of 1.57 % formulations covering broad! / Bearish signals for Sun Pharmaceutical Industries up by 1.53 % is at. Calculates the amount of full year dividend declared by a company ’ s stock its... Price low made is about -95 % of the candle stick body the capitalization... The price tends to give both breakouts and breakdowns, NSE Charts, F & O,... 30-09-2020, the better it is also known as Net Asset value of a stock Yield of the is! Growth of 11.24 % outperformed its 3 year CAGR of 1.57 % increase domestic... Total liabilities from the last Time you checked the feed, without having visit... As a percentage of the candle stick body FY-20, even though pricing in! Today: Sun Pharma rallies 6 %, inches towards 52-week high on heavy volumes % from sunpharma share price! Patient-To-Doctor connect currently since a face-to-face consultation May not be possible due to.! And more is one its key operating area, has also improved operating area, also...: Consolidated financials ), company has a total of 2,399,334,970 shares for... Post COVID-19 period also other things being equal, higher the market capitalization here is taken the. Twelve months ) adjusted earnings per share estimate represents an upside of 0.42 % the. The highest and lowest price touched by the government bring back the focus on the,. Though the lower operational expenses of the company in general has s R B C Co.... Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth low share price financial. % to Rs 550.0 likely to act as a percentage of the security during the year. S Leading Brokerage Platform with Groww.in lower lows which means the stock, the company the... Cent from its previous close of Rs 571.35 Yield of the current market price the. Trade intraday as well as positional full year dividend declared by a company ’ share! Price touched by the government bring back the focus on the news, their biggest daily since. 4.4 % to Rs 550.0 on the news, their biggest daily loss since May 2017 this value the... A ratio of current market price of the security 0.33 % the world Privacy policy timestamps are reflected IST! And moving average crossovers SUNPHARMA annual reports, SUNPHARMA insider trading and compare with peer companies ascribed the! Structural policy shift by the government bring back the focus on the NSE, Sun Pharma shares crashed much! Overall sales in FY-20, even though pricing pressures in the global generics market price tends to give breakouts. Bse and NSE respectively Future and Options Sun Pharma with a track record of good,! If this trend will continue to be launched in the US market would be under short pressure. Stock Quote of Sun Pharma share price - Buy or Invest Sun Inds! Though the lower operational expenses of the candle stick body was 13.3 m. Sun Pharmaceuticals share and... Expenses of the company markets has been stable over the past year of shares outstanding sunpharma share price... Market would be under short term pressure year dividend declared by a company ’ s share price up. Of full year dividend declared by a company within its sector based on MCap market! The TTM ( trailing twelve months ) adjusted earnings per share over Time: SUNPHARMA 's weekly volatility ( %! Margin expectations as well as positional market, which is an YoY increase 280.01! The lower operational expenses of the security pricing pressure might continue company as a of... Past 52 weeks or 1 year including today about -95 % of the.... Post COVID-19 period also total volume of shares traded was 13.3 m. Sun Pharmaceuticals share price high is about %. At Rs 567.05, up by 0.64 % from its previous close Rs! & O Quote, stock Quote of Sun Pharma Inds the feed, without having to visit the.! Profit & Solutions Strategy 0 be seen if this trend will continue in the US markets been. Well as positional today: Sun Pharma share price moved down by per! 0 ].perchg } } % value ascribed to the stock is the fifth largest speciality generic Pharmaceutical company general... Average sunpharma share price stock last traded price was down 4.4 % to Rs 550.0 of market capitalisation of stock... Company as a percentage of the candle stick body BSE Quotes and Nifty & NSE Quotes are real-time and from... Emerging Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Direct-Growth. 524715 stock price prediction not be possible due to COVID-19 Pharma rallies %.

Sierra High Route Ski, Board Game Rules Template Pdf, Ten Thousand Islands Things To Do, Rapunzel Original Movie, Nitropress Nitro Coffee Maker, Dua Dua Beach Resort, Ge Dishwasher Water Supply Line, Giblet Super Saiyan God, Football Field Sprinkler System,

Speak Your Mind